Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study

✍ Scribed by Pro, B.; Advani, R.; Brice, P.; Bartlett, N. L.; Rosenblatt, J. D.; Illidge, T.; Matous, J.; Ramchandren, R.; Fanale, M.; Connors, J. M.; Yang, Y.; Sievers, E. L.; Kennedy, D. A.; Shustov, A.

• Book ID: 118056260
• Publisher: American Society of Clinical Oncology
• Year: 2012
• Tongue: English
• Weight: 395 KB
• Volume: 30
• Category: Article
• ISSN: 0732-183X
• DOI: 10.1200/jco.2011.38.0402